adplus-dvertising
Connect with us

Business

'Taken out of context': Doctors respond to WHO chief scientist's comments on mixing COVID-19 vaccines – CTV News

Published

 on


TORONTO —
Experts in Canada say that comments by the World Health Organization’s chief scientist on mixing and matching COVID-19 vaccine doses have been taken out of context and that doing so under public health guidelines is safe and effective.

The WHO’s Dr. Soumya Swaminathan said during an online briefing Monday that there is little data on mixing and matching vaccines and that it could be a “chaotic” situation if “citizens start deciding” when they should be taking “a second or a third or a fourth dose” and from which vaccine manufacturer.

“To be charitable here, I think this was a conversation that was taken out of context,” Dr. Sumon Chakrabarti, an infectious disease doctor, told CTV News Channel on Tuesday.

300x250x1

In some parts of the world, he said, people have taken it upon themselves to get multiple doses of various COVID-19 vaccines so they can travel.

“We’re seeing in other parts of the world, some people are getting a certain vaccine, say Sinopharm – not available in Canada — and then trying to get another two doses of vaccine to get double vaccinated or get a vaccine that will satisfy some sort of condition,” he said.

Some countries will not allow travellers to cross their borders without full vaccination via specific authorized vaccines. Others, including Canada, require travellers to quarantine for 14 days unless they’ve been fully immunized with one of the vaccines authorized for use in the country.

In a statement to CTVNews.ca, the WHO said that Swaminathan’s remarks were targeted towards individuals.

“At our Global press conference on COVID 19, Dr. Soumya Swaminathan explained that individuals should not decide for themselves, public health agencies can, based on available data. Data from mix and match studies of different vaccines are awaited – immunogenicity and safety both need to be evaluated,” the statement said.

In Canada, the National Advisory Committee on Immunization (NACI) and Public Health Agency of Canada have said mixing and matching doses is safe based on available evidence. In a June update to COVID-19 vaccine recommendations, NACI said that the mRNA vaccines can be used interchangeably if the original dose is not available, and that a second dose of mRNA vaccine is recommended for those who got AstraZeneca as a first dose.

“I agree that mixing and matching doses of vaccine is safe, we have evidence for this, we’ve been doing it, and it works so I think that that discussion was something that was not applicable to what’s happening in Canada,” Chakrabarti added.

Studies conducted in other countries have shown that mixing mRNA and AstraZeneca vaccines can promote a stronger immune response.

“We have some evidence out of Spain, in England, and also Germany showing that you can actually put these two vaccines together, and you see actually a boost in the amount of antibodies you get,” he said.

Canadian researchers are conducting their own study on mixing and matching vaccines. The study will investigate the impacts of the use of COVID-19 vaccines from different manufacturers in adult participants.

Dr. Joanne Langley, co-principal investigator of the MOSAIC study and infectious disease physician, told CTVNews.ca in a phone interview on Tuesday that the Canadian study is investigating antibody responses to mix-and-match vaccine schedules and will document how participants are feeling in the short-term and long-term.

Due to Canada’s quickening vaccine rollout, the researchers have run into issues getting enough participants for the study, particularly as it also aims to examine extended intervals of up to 70 days between doses.

“They think they can get it quicker through public health and that may not be the case,” Langley said. “There is an interval so you can get it as soon as 28 days from your first vaccine or as long as the 70 days, but if you’re already at two months from your first vaccine that means it’s only two weeks to get your next one.”

The study is done in conjunction with the COVID-19 Immunity Task Force, Vaccine Surveillance Reference Group, Canadian Immunization Research Network and Dalhousie University and it will investigate mixing and matching vaccines and extended dose intervals in 1,300 adults across Canada at Canadian Immunization Research Network clinical trial sites. These sites are located in Nova Scotia, Quebec, Ontario, Manitoba, Alberta and B.C.

And while Langley agrees that there is room for more data and evidence, there are currently at least 26 studies on mixing vaccines being conducted worldwide. She too thinks Swaminathan’s remarks were taken out of context.

“She was referring in particular to what some people are talking about doing: getting a third and a fourth dose, and that absolutely should only be done if it’s recommended by public health people,” she said. “In Canada you couldn’t do that. But in some countries, you could access the vaccine as an individual.”

COVID-19 vaccines aren’t the only ones we see mixed and matched with other brands. This happens with other vaccinations that Canadians need occasional boosters for.

“We also know from previous vaccines, outside of COVID, that this works,” Chakrabarti said. “For example, with pneumococcal vaccinations, this is something that’s safe.”

In a statement to CTVNews.ca, the Public Health Agency of Canada also said that vaccine interchangeability happens regularly in Canada.

“Vaccine interchangeability is not a new concept. Similar vaccines from different manufacturers are used when vaccine supply or public health programs change. Different vaccine products have been used to complete a vaccine series for influenza, hepatitis A, and others,” the statement read.

The WHO’s latest messaging may have also been an attempt at stopping countries from hoarding COVID-19 vaccines for future booster shots, one infectious disease doctor said.

“I do sincerely believe that it was a well-intended message aimed at preventing the idea of hoarding too many doses of vaccines for booster shots, and potentially third or even fourth doses, especially when you’re dealing with a situation where COVAX has not worked ideally for under resourced parts of the world,” Dr. Abdu Sharkawy told CTV’s Your Morning on Tuesday.

Swaminathan did caution on Monday that “if 11 high and upper middle income countries decide… that they will go for a booster for their populations or even subgroups, this will require an additional 800 million doses of vaccine.” She said that would affect the global vaccine supply at a point “when there is no scientific evidence to suggest that boosters are definitely needed.”

Despite good intentions, Sharkawy said that he was surprised that Swaminathan said mixing and matching COVID-19 vaccines was an “evidence free zone,” as studies around the world have yielded evidence and real-world evidence is taking place.

“When you’re talking about the science behind this protocol, and we’re dealing with emerging real-world evidence from multiple parts of Europe, that shows that this is a safe and effective strategy to use,” he said. “So for any Canadian who did receive a multi-platform vaccine protocol, including my own wife, I say you have nothing to fear. The science is very sound.”

For those who did mix their vaccine doses, Langley said they did the right thing by following public health advice and that advice hasn’t changed.

“The most important thing is to have two doses of an authorized COVID vaccine, so that you will reduce your likelihood of getting COVID serious complications,” she said.

For Chakrabarti, he has no doubt in the safety of mixing and matching and even recommended his own father mix doses.

“I wouldn’t do that unless I thought it was entirely safe.”

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Tesla Promises Cheap EVs by 2025 | OilPrice.com – OilPrice.com

Published

 on



Tesla Promises Cheap EVs by 2025 | OilPrice.com



300x250x1


Charles Kennedy

Charles Kennedy

Charles is a writer for Oilprice.com

More Info

Related News

Tesla

Tesla has promised to start selling cheaper models next year, days after a Reuters report revealed that the company had shelved its plans for an all-new Tesla that would cost only $25,000.

The news that Tesla was scrapping the Model 2 came amid a drop in sales and profits, and a decision to slash a tenth of the company’s global workforce. Reuters also noted increased competition from Chinese EV makers.

Tesla’s deliveries slumped in the first quarter for the first annual drop since the start of the pandemic in 2020, missing analyst forecasts by a mile in a sign that even price cuts haven’t been able to stave off an increasingly heated competition on the EV market.

Profits dropped by 50%, disappointing investors and leading to a slump in the company’s share prices, which made any good news urgently needed. Tesla delivered: it said it would bring forward the date for the release of new, lower-cost models. These would be produced on its existing platform and rolled out in the second half of 2025, per the BBC.

Reuters cited the company as warning that this change of plans could “result in achieving less cost reduction than previously expected,” however. This suggests the price tag of the new models is unlikely to be as small as the $25,000 promised for the Model 2.

The decision is based on a substantially reduced risk appetite in Tesla’s management, likely affected by the recent financial results and the intensifying competition with Chinese EV makers. Shelving the Model 2 and opting instead for cars to be produced on existing manufacturing lines is the safer move in these “uncertain times”, per the company.

Tesla is also cutting prices, as many other EV makers are doing amid a palpable decline in sales in key markets such as Europe, where the phaseout of subsidies has hit demand for EVs seriously. The cut is of about $2,000 on all models that Tesla currently sells.

By Charles Kennedy for Oilprice.com

More Top Reads From Oilprice.com:

Join the discussion | Back to homepage

Related posts

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Why the Bank of Canada decided to hold interest rates in April – Financial Post

Published

 on


Article content

Divisions within the Bank of Canada over the timing of a much-anticipated cut to its key overnight interest rate stem from concerns of some members of the central bank’s governing council that progress on taming inflation could stall in the face of stronger domestic demand — or even pick up again in the event of “new surprises.”

“Some members emphasized that, with the economy performing well, the risk had diminished that restrictive monetary policy would slow the economy more than necessary to return inflation to target,” according to a summary of deliberations for the April 10 rate decision that were published Wednesday. “They felt more reassurance was needed to reduce the risk that the downward progress on core inflation would stall, and to avoid jeopardizing the progress made thus far.”

Article content

300x250x1

Others argued that there were additional risks from keeping monetary policy too tight in light of progress already made to tame inflation, which had come down “significantly” across most goods and services.

Some pointed out that the distribution of inflation rates across components of the consumer price index had approached normal, despite outsized price increases and decreases in certain components.

“Coupled with indicators that the economy was in excess supply and with a base case projection showing the output gap starting to close only next year, they felt there was a risk of keeping monetary policy more restrictive than needed.”

In the end, though, the central bankers agreed to hold the rate at five per cent because inflation remained too high and there were still upside risks to the outlook, albeit “less acute” than in the past couple of years.

Despite the “diversity of views” about when conditions will warrant cutting the interest rate, central bank officials agreed that monetary policy easing would probably be gradual, given risks to the outlook and the slow path for returning inflation to target, according to the summary of deliberations.

Article content

They considered a number of potential risks to the outlook for economic growth and inflation, including housing and immigration, according to summary of deliberations.

The central bankers discussed the risk that housing market activity could accelerate and further boost shelter prices and acknowledged that easing monetary policy could increase the likelihood of this risk materializing. They concluded that their focus on measures such as CPI-trim, which strips out extreme movements in price changes, allowed them to effectively look through mortgage interest costs while capturing other shelter prices such as rent that are more reflective of supply and demand in housing.

Recommended from Editorial

  1. Bank of Canada governor Tiff Macklem during a news conference in Ottawa.

    BoC ‘committed to finishing the job’ on inflation:‘ Macklem

  2. Bank of Canada governor Tiff Macklem at a press conference in Ottawa.

    Time for Macklem to turn before it’s too late

  3. Canada's inflation rate picked up slightly in March, but the consumer price index (CPI) release suggested that core inflation continued to slow.

    ‘Welcome news’ on inflation raises odds of rate cut

They also agreed to keep a close eye on immigration in the coming quarters due to uncertainty around recent announcements by the federal government.

“The projection incorporated continued strong population growth in the first half of 2024 followed by much softer growth, in line with the federal government’s target for reducing the share of non-permanent residents,” the summary said. “But details of how these plans will be implemented had not been announced. Governing council recognized that there was some uncertainty about future population growth and agreed it would be important to update the population forecast each quarter.”

• Email: bshecter@nationalpost.com

Bookmark our website and support our journalism: Don’t miss the business news you need to know — add financialpost.com to your bookmarks and sign up for our newsletters here.

Share this article in your social network

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Meta shares sink after it reveals spending plans – BBC.com

Published

 on


Woman looks at phone in front of Facebook image - stock shot.

Shares in US tech giant Meta have sunk in US after-hours trading despite better-than-expected earnings.

The Facebook and Instagram owner said expenses would be higher this year as it spends heavily on artificial intelligence (AI).

Its shares fell more than 15% after it said it expected to spend billions of dollars more than it had previously predicted in 2024.

300x250x1

Meta has been updating its ad-buying products with AI tools to boost earnings growth.

It has also been introducing more AI features on its social media platforms such as chat assistants.

The firm said it now expected to spend between $35bn and $40bn, (£28bn-32bn) in 2024, up from an earlier prediction of $30-$37bn.

Its shares fell despite it beating expectations on its earnings.

First quarter revenue rose 27% to $36.46bn, while analysts had expected earnings of $36.16bn.

Sophie Lund-Yates, lead equity analyst at Hargreaves Lansdown, said its spending plans were “aggressive”.

She said Meta’s “substantial investment” in AI has helped it get people to spend time on its platforms, so advertisers are willing to spend more money “in a time when digital advertising uncertainty remains rife”.

More than 50 countries are due to have elections this year, she said, “which hugely increases uncertainty” and can spook advertisers.

She added that Meta’s “fortunes are probably also being bolstered by TikTok’s uncertain future in the US”.

Meta’s rival has said it will fight an “unconstitutional” law that could result in TikTok being sold or banned in the US.

President Biden has signed into law a bill which gives the social media platform’s Chinese owner, ByteDance, nine months to sell off the app or it will be blocked in the US.

Ms Lund-Yates said that “looking further ahead, the biggest risk [for Meta] remains regulatory”.

Last year, Meta was fined €1.2bn (£1bn) by Ireland’s data authorities for mishandling people’s data when transferring it between Europe and the US.

And in February of this year, Meta chief executive Mark Zuckerberg faced blistering criticism from US lawmakers and was pushed to apologise to families of victims of child sexual exploitation.

Ms Lund-Yates added that the firm has “more than enough resources to throw at legal challenges, but that doesn’t rule out the risks of ups and downs in market sentiment”.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Trending